Just a spoonful of sugar

News

The California NanoSystems Institute (CNSI) at UCLA has announced a partnership with Abraxis BioScience to collaborate on nanobiotechnology research to develop new medicinal technologies

The

(CNSI) at

has announced a partnership with the global biopharmaceutical company

to collaborate on nanobiotechnology research to develop new technologies in medicine.

Abraxis has agreed to contribute $10m over 10 years to fund collaborative projects at UCLA’s new CNSI building. The new research laboratory will focus on quickly translating scientific discoveries into practical applications.

By joining the CNSI Partners Program, Abraxis and CNSI will be able to jointly research ways to diagnose and treat life-threatening diseases.

‘Nanosystems research is breaking down the barriers between disciplines to achieve a seamless integration between chemistry, physics, biology and engineering in all of their different forms,’ said Fraser Stoddart, CNSI director and UCLA’s Fred Kavli professor of nanosystems sciences.

Register now to continue reading

Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.  

Benefits of registering

  • In-depth insights and coverage of key emerging trends

  • Unrestricted access to special reports throughout the year

  • Daily technology news delivered straight to your inbox

Register
Or continue by

Signing in with your registered email address